标题
Diabetes and lipid metabolism
作者
关键词
Diabetes mellitus, Lipid metabolism, Diabetic dyslipidemia, Epidemiology, Pathophysiology, Treatment, Residual cardiovascular risk
出版物
Hormones-International Journal of Endocrinology and Metabolism
Volume 17, Issue 1, Pages 61-67
出版商
Springer Nature
发表日期
2018-04-30
DOI
10.1007/s42000-018-0014-8
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The prevalence of dyslipidemia and associated factors in children and adolescents with type 1 diabetes
- (2017) Tuba Bulut et al. JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM
- 2017 Focused Update of the 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk
- (2017) Donald M. Lloyd-Jones et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitors: Shaping the future after the further cardiovascular outcomes research with PCSK9 inhibition in subjects with elevated risk (FOURIER) trial
- (2017) Niki Katsiki et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement
- (2017) Vasilios G. Athyros et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
- (2017) Marc S. Sabatine et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients
- (2017) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Omega-3 Fatty Acids and Cardiovascular Disease: Summary of the 2016 Agency of Healthcare Research and Quality Evidence Review
- (2017) Ethan Balk et al. Nutrients
- Treatment of Dyslipidemias to Prevent Cardiovascular Disease in Patients with Type 2 Diabetes
- (2017) Maryam Khavandi et al. Current Cardiology Reports
- Diabetic Dyslipidemia Review: An Update on Current Concepts and Management Guidelines of Diabetic Dyslipidemia
- (2016) Andrew W. Dake et al. AMERICAN JOURNAL OF THE MEDICAL SCIENCES
- 2016 European Guidelines on cardiovascular disease prevention in clinical practice
- (2016) Massimo F. Piepoli et al. ATHEROSCLEROSIS
- 9. Cardiovascular Disease and Risk Management
- (2016) DIABETES CARE
- Beta cell function and ongoing autoimmunity in long-standing, childhood onset type 1 diabetes
- (2016) Georgina M. Williams et al. DIABETOLOGIA
- Effect of micronized fenofibrate on microvascular complications of type 2 diabetes: a systematic review
- (2016) Leszek Czupryniak et al. EXPERT OPINION ON PHARMACOTHERAPY
- New insights into the pathophysiology of dyslipidemia in type 2 diabetes
- (2015) Marja-Riitta Taskinen et al. ATHEROSCLEROSIS
- Variable effects of statins on glucose homeostasis parameters and their diabetogenic role
- (2015) Michael S. Kostapanos et al. DIABETOLOGIA
- Pathophysiology of diabetic dyslipidaemia: where are we?
- (2015) Bruno Vergès DIABETOLOGIA
- Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
- (2015) Christopher P. Cannon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Intestinal Lipid Handling
- (2014) Alain Veilleux et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- New and emerging regulators of intestinal lipoprotein secretion
- (2014) Changting Xiao et al. ATHEROSCLEROSIS
- Postprandial hypertriglyceridemia as a coronary risk factor
- (2014) Jan Borén et al. CLINICA CHIMICA ACTA
- Genetic, epidemiologic and clinical data strongly suggest that fasting or non-fasting triglycerides are independent cardiovascular risk factors
- (2014) Vasilios G. Athyros et al. CURRENT MEDICAL RESEARCH AND OPINION
- Hypertriglyceridaemia, Postprandial Lipaemia and Non-HDL Cholesterol
- (2014) Claudia Stefanutti et al. CURRENT PHARMACEUTICAL DESIGN
- 8. Cardiovascular Disease and Risk Management
- (2014) DIABETES CARE
- Effects of Extended-Release Niacin with Laropiprant in High-Risk Patients
- (2014) NEW ENGLAND JOURNAL OF MEDICINE
- Systematic Review: Association of Low-Density Lipoprotein Subfractions With Cardiovascular Outcomes
- (2013) Stanley Ip ANNALS OF INTERNAL MEDICINE
- Type 2 diabetes in South Asians: similarities and differences with white Caucasian and other populations
- (2013) Unjali P. Gujral et al. Annals of the New York Academy of Sciences
- Fibrate therapy and circulating adiponectin concentrations: A systematic review and meta-analysis of randomized placebo-controlled trials
- (2013) Amirhossein Sahebkar et al. ATHEROSCLEROSIS
- 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
- (2013) Neil J. Stone et al. CIRCULATION
- Statin–fibrate combination therapy is safe and effective in normalizing lipid profile and in keeping cardiovascular event rates low
- (2013) Vasilios G. Athyros et al. CURRENT MEDICAL RESEARCH AND OPINION
- Effects of ezetimibe on atherogenic lipoproteins and glucose metabolism in patients with diabetes and glucose intolerance
- (2013) Tetsuji Tsunoda et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Global estimates of diabetes prevalence for 2013 and projections for 2035
- (2013) L. Guariguata et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Lipoprotein subclass profiles in individuals with varying degrees of glucose tolerance: a population-based study of 9399 Finnish men
- (2013) J. Wang et al. JOURNAL OF INTERNAL MEDICINE
- Diabetes: a 21st century challenge
- (2013) Paul Z Zimmet et al. Lancet Diabetes & Endocrinology
- Mechanisms of Diabetic Dyslipidemia: Relevance for Atherogenesis
- (2012) Marcello Arca et al. Current Vascular Pharmacology
- Rising Incidence of Type 1 Diabetes Is Associated With Altered Immunophenotype at Diagnosis
- (2012) A. E. Long et al. DIABETES
- GERODIAB: Glycaemic control and 5-year morbidity/mortality of type 2 diabetic patients aged 70 years and older: 1. Description of the population at inclusion
- (2012) J. Doucet et al. DIABETES & METABOLISM
- Clinical benefits of ezetimibe use: is absence of proof, proof of absence?
- (2012) Ioanna Gouni-Berthold et al. EXPERT OPINION ON PHARMACOTHERAPY
- Role of the Gut in Lipid Homeostasis
- (2012) Nada A. Abumrad et al. PHYSIOLOGICAL REVIEWS
- Cardiovascular Events in Patients Received Combined Fibrate/Statin Treatment versus Statin Monotherapy: Acute Coronary Syndrome Israeli Surveys Data
- (2012) Alexander Tenenbaum et al. PLoS One
- Thinking Beyond Traditional Cardiovascular Risk Factors
- (2011) Niki Katsiki et al. ANGIOLOGY
- ESC/EAS Guidelines for the management of dyslipidaemias
- (2011) Alberico L. Catapano et al. ATHEROSCLEROSIS
- News from the literature: Focus on joint ESC/EAS dyslipidemia guidelines
- (2011) Jane Stock ATHEROSCLEROSIS
- Regulation of chylomicron production in humans
- (2011) Changting Xiao et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- “European Panel On Low Density Lipoprotein (LDL) Subclasses”: A Statement on the Pathophysiology, Atherogenicity and Clinical Significance of LDL Subclasses: Executive Summary
- (2011) Dimitri P. Mikhailidis et al. Current Vascular Pharmacology
- IDF Diabetes Atlas: Global estimates of the prevalence of diabetes for 2011 and 2030
- (2011) David R. Whiting et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management
- (2011) M. John Chapman et al. EUROPEAN HEART JOURNAL
- Remnant Lipoproteins As Strong Key Particles to Atherogenesis
- (2011) Yoshio Fujioka et al. Journal of Atherosclerosis and Thrombosis
- Treatment of dyslipidemia in patients with type 2 diabetes
- (2011) Krishnaswami Vijayaraghavan Lipids in Health and Disease
- Costos de la Diabetes en Ameŕica Latina: Evidencias del Caso Mexicano
- (2011) Armando Arredondo et al. VALUE IN HEALTH
- "If it ain't broke, don't fix it": a commentary on the positive-negative results of the ACCORD Lipid study
- (2010) Alexander Tenenbaum et al. Cardiovascular Diabetology
- Do Statins Beneficially or Adversely Affect Glucose Homeostasis?
- (2010) Michael S. Kostapanos et al. Current Vascular Pharmacology
- Atherogenic Dyslipidemia: Cardiovascular Risk and Dietary Intervention
- (2010) Kiran Musunuru LIPIDS
- Combination Lipid Therapy in Type 2 Diabetes
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Triglycerides and Vascular Risk: Insights from Epidemiological Data and Interventional Studies
- (2009) Konstantinos Tziomalos et al. CURRENT DRUG TARGETS
- Global estimates of the prevalence of diabetes for 2010 and 2030
- (2009) J.E. Shaw et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Diabetic dyslipidemia and atherosclerosis: Evidence from clinical trials
- (2008) John A. Farmer Current Diabetes Reports
- The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in dyslipidaemic patients
- (2008) Jean-Charles Fruchart et al. Diabetes & Vascular Disease Research
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More